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ABSTRACT
Objective: This study aims to analyze the clinical charac-
teristics and diagnostic features of ovarian fibromas and to
evaluate the efficacy and safety of laparoscopic surgery
for ovarian fibromas.
Methods: We reviewed the records of 47 consecutive
women who underwent laparoscopic or laparotomic sur-
geries and whose final histopathological diagnoses were
ovarian fibroma, cellular fibroma, or fibrothecoma from
January 1999 to August 2010.
Results: During the study period, 49 tumors were re-
moved from 47 women including 27 ovarian fibromas, 19
fibrothecomas, and 3 cellular fibromas. The preoperative
diagnoses were ovarian fibroma in 25 women (53.2%) and
uterine myoma in 16 women (34.0%). A high serum CA
125 level (35U/mL) was observed in 15 women, and
serum CA 125 level was significantly higher in women
with ascites (P0.001). The tumors were removed sur-
gically in all women, using the laparotomic approach in 16
women (34.0%) and the laparoscopic approach in 31
women (66.0%). The laparoscopic surgery had the advan-
tages of shorter hospital stay and faster return of bowel
activities compared to laparotomy.
Conclusions: Ovarian fibromas are often misdiagnosed
as uterine myomas, and sometimes mistaken for a malig-
nant tumor of the ovary preoperatively. Laparoscopic sur-
gery can be an effective and safe surgical approach for
managing ovarian fibromas.
Key Words: Cellular fibroma, Fibroma, Fibrothecoma,
Laparoscopy, Ovary.
INTRODUCTION
Ovarian fibroma is the most common benign solid tumor
of the ovary, which accounts for 1% to 4% of benign
ovarian tumors.1–4 Ovarian fibromas are often difficult to
diagnose preoperatively and are commonly misdiagnosed
as uterine myomas, because of the solid nature shown in
ultrasonographic findings. Ascites is sometimes present,
and the serum CA 125 level increases, which may lead to
the mistaken diagnosis as a malignant tumor of the
ovary.2,5 The treatment of choice for ovarian fibromas is
surgical removal, but the operative approach to managing
ovarian fibromas has been discussed infrequently. Sur-
geons are reluctant to use laparoscopic surgical manage-
ment, because it can be difficult to safely remove the
excised tumors from the abdominal cavity.
We analyzed the clinical characteristics and diagnostic
features of ovarian fibromas and evaluated the efficacy
and safety of laparoscopic surgery as a treatment for
ovarian fibromas by comparing the outcomes of laparo-
scopic surgery with those of laparotomy.
METHODS
In this study, we retrospectively reviewed the records of
47 consecutive women who underwent laparoscopic or
laparotomic surgeries and whose final histopathological
diagnoses were ovarian fibroma, cellular fibroma, or fi-
brothecoma at Kangbuk Samsung Hospital from January
1999 to August 2010. In all women, the initial preoperative
evaluation included a medical history, physical examina-
tion, pelvic examination, and gynecological ultrasonogra-
phy. The serum levels of tumor markers (CA125 and CA
19-9) and results of computed tomography (CT) or mag-
netic resonance imaging (MRI) were checked. We re-
viewed the clinical charts and analyzed the data on the
women’s age, parity, body mass index (BMI), previous
history of abdominal surgery, symptoms, preoperative di-
agnosis, ultrasonographic findings, serum levels of tumor
markers, diameter of the mass, operative procedures, op-
erating time, method of surgical approaches (laparoscopy
or laparotomy), concurrent surgeries, change in hemoglo-
bin concentration from before surgery to postoperative
day 1, hospital stay, and complications.
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SCIENTIFIC PAPERLaparotomy was performed to treat 16 women (laparot-
omy group) and laparoscopy was used to treat 31 women
(laparoscopy group). In our hospital, laparoscopy was not
actively conducted before March 2003. So, the laparos-
copy group included 28 women who were treated after
2003 and 3 women before 2003. The laparotomy group
included 7 women after 2003 who had refused to undergo
laparoscopy, and 9 women before 2003. There was no
conversion to laparotomy.
For the surgical parameters, the operating time was de-
fined as the time elapsed from the incision of the skin to
the closure of the skin in laparotomy and as the time
elapsed from the insertion of the first trocar to the closure
of the trocar site in laparoscopy. The return of bowel
activity was defined as the period from the end of general
anesthesia to the first occurrence of bowel gas passage.
This study was approved by Kangbuk Samsung Hospital
Institutional Review Board.
Statistical Analysis
The data are expressed as the median and range. The data
were analyzed using SAS software, version 9.1 (SAS Insti-
tute Inc., Cary, NC, USA). Frequency distributions were
compared using chi-squared and Fisher’s exact tests, and
median values were compared using the Student t test and
Mann-Whitney U test. Two-sided P-values 0.05 were
considered significant.
RESULTS
During the study period, women underwent surgery for
benign ovarian tumors in our hospital, of which 49 ovar-
ian fibromas, including fibromas, fibrothecomas, and cel-
lular fibromas, were diagnosed based on the histopatho-
logical results in 47 women (2.0%). The clinical characteristics of
these 47 women are summarized in Table 1. Ultrasono-
graphic examinations were performed in all women, and
CT or MRI was performed in 19 women (40.4%). Ascites
was observed in 15 women (31.9%), and the estimated
volume of ascites ranged from 50mL to 3500mL. The
macroscopic appearance of the tumors observed during
the surgery in all women was of a solid nature, with a
white or whitish-yellow color and a smooth surface. The
preoperative ultrasonographic image and the laparo-
scopic views of the tumor are shown in Figure 1.
The most frequent symptoms were abdominal discomfort
and pain (53.2%), followed by no symptoms. Fibroma was
detected incidentally in 2 women, and their preoperative
diagnoses were carcinoma in situ of the uterine cervix and
tubal pregnancy, respectively. Other disorders found along
with ovarian fibroma included uterine myomas in 20 women
(42.5%), serous cystadenoma of the ipsilateral ovary in 2
women, and mature cystic teratoma of the ipsilateral ovary in
1 woman. Bilaterality was found in 2 women: fibroma and
cellular fibroma in each ovary in one woman, and fibroma
and fibrothecoma in the other woman. Torsion was ob-
served in 3 women (6.4%), who were all menopausal, and
the diameters of the tumors were 15cm, 10cm, and 8cm,
respectively.
Table 1.
Clinical Characteristics of the Women
Characteristics Median (Range)
Age (years) 51 (25–87)
Parity 3 (0–8)
Body mass index (kg/m
2) 22.3 (17.9–
32.5)
Serum CA 125 level (U/mL) (n30) 25.6 (3.1–
442.6)
Serum CA 19-9 level (U/mL) (n26) 17.0 (4.5–
145.5)
Associated symptoms n (%)
Abdominal discomfort or pain 25 (53.2)
Asymptomatic 15 (31.9)
Palpable abdominal mass 6 (12.8)
Dysuria 1 (2.1)
Preoperative diagnosis
Benign ovarian tumors including
ovarian fibroma
25 (53.2)
Uterine myoma 16 (34.0)
Ovarian malignant tumor 4 (8.5)
Carcinoma in situ of the uterine
cervix
1 (2.1)
Tubal pregnancy 1 (2.1)
Women with ascites (50–3500mL) 15 (31.9)
Postmenopausal women 23 (48.9)
Location of ovarian fibroma
Right 30 (63.8)
Left 15 (31.9)
Bilateral 2 (4.2)
Histopathological results (n47)
Fibroma 27 (55.1)
Fibrothecoma 19 (38.8)
Cellular fibroma 3 (6.1)
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16 underwent laparotomy. The comparative results of
both operative approaches are summarized in Table 2.
Shorter hospital stay and faster return of bowel activity
were observed in the laparoscopy group.
Preoperative serum CA 125 level was measured in 32
women, and of those, both serum CA 125 and CA 19-9
levels were measured in 28 women. Serum CA 125 level
was high (35U/mL) in 15 women, and serum CA 19-9
level was high (37U/mL) in 3 women. As shown in
Table 3, the number of women with high serum CA 125
level was significantly higher in women with ascites
(P0.001).
DISCUSSION
Ovarian fibromas, which belong to the group of sex cord-
stromal cell tumors, are the most common benign solid
tumor of the ovary. In almost all cases, they are benign
and curable by surgical excision. These tumors occur
generally in older women. In our study, 80.9% of the
women were older than 40 years of age, and 49.0% of the
women were menopausal. Two women (4.3%) had bilat-
eral tumors, and other studies have reported an incidence
of bilateral tumors of 0% to 11.76%.1–3 In our study, the
tumor was found more often on the right side, which is
different from the previous results that reported the higher
incidence on the left side.2,3
Ovarian fibromas are often difficult to diagnose before
surgery. There are no characteristic symptoms and the
ultrasonographic findings cannot easily distinguish ovar-
ian fibromas from uterine myomas having. In this study,
16 women (34.0%) were misdiagnosed preoperatively as
uterine myoma. Leung et al3 reported that 34.7% of
women were misdiagnosed preoperatively as having uter-
ine myoma, and only 21.7% were diagnosed accurately as
having ovarian fibroma.
In our study, 15 (31.9%) of the women had ascites. Other
studies have found ascites in up to 67% of women when
including small amounts of ascites found during surgery.
The relationship between fibroma and ascites is explained
by observations showing that the cortex layer of the ovary,
which is the origin of the fibroma, does not have lymph
vessels, so the tumor itself forms a transudate.6 Ascites
disappears after the surgical removal of the tumor.7 In our
women, high serum CA 125 level was related significantly
to the presence of ascites (Table 3), which is consistent
with other study results showing a relationship between
increased serum CA 125 level and ascites.5,7,8 However,
further studies are needed to determine whether the high
serum CA 125 level is related directly to ovarian fibroma or
to the accompanying ascites.
Microscopically, ovarian fibromas are solid tumors
comprising spindly fibroblastic cells.4,6,9 Fibrothecomas
include lipid-laden theca cells, which form thecomas, in
addition to the cells that form fibromas, and this termi-
nology is used when the distinction between these 2
forms is not clear.9 Cellular fibroma, which is a rare
form of ovarian fibroma, can also occur. A tumor com-
prising cells with closely packed nuclei with absent or
minimal nuclear atypia and 1 to 3 mitoses/10 high-
power fields is classified as cellular fibroma.10 A tumor
showing moderate nuclear atypia and 3 mitoses/10
high-power fields has a malignant potential and is des-
ignated as a fibrosarcoma.
Surgery is the recommended treatment for ovarian fi-
broma. Salpingo-oophorectomy can be considered in peri-
menopausal or postmenopausal women, and cystectomy
only can be performed in young women.
Our comparative analysis of the outcomes between the
laparoscopy group and the laparotomy group showed
that laparoscopic surgery has the advantages of shorter
hospital stay and faster return of bowel activities. The
other characteristics were not significantly different be-
Figure 1. (A) Transvaginal ultrasonographic scan of the fibroma
showing the hypoechoic image that cannot be distinguished
easily from uterine myoma preoperatively; (B) Laparoscopic
view shows the right ovarian fibroma with whitish color and
smooth surface; (C) The tumor is being resected away from the
right ovary using a Harmonic shears; (D) We are putting the
resected fibroma into an endobag. The tumor can be safely
removed by using an endobag.
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erative diagnosis of an ovarian fibroma is not easy, and the
tumor is not often diagnosed accurately until during the
surgery. With the advances in operative instruments and
techniques, laparoscopic surgery has become more pop-
ular, and it is being used frequently by many gynecolo-
gists. It is possible to encounter ovarian fibromas inciden-
tally during the laparoscopy, which is of concern because
an ovarian fibroma has a solid nature and is difficult to
remove from the abdominal cavity. We safely removed the
tumor using an endobag by exposing the opening of the
endobag to the outside of the abdominal cavity through
the 12-mm trocar site and morcellating the tumor with
ovum forceps without allowing them to spill into the
abdominal cavity. When performing laparoscopically assisted
vaginal hysterectomy, the tumor can be removed safely by
puttingitinanendobagandremovingtheendobagthroughthe
vagina after hysterectomy. This is possible because a fibroma is
not as solid as a uterine myoma and can be morcellated into
pieces easily when pulled by forceps.
Table 2.
Characteristics and Operative Procedures
Characteristics Laparoscopy Group
[n31; Median (range)]
Laparotomy Group
[n16; Median (range)]
P Value
Age (years) 49 (25–82) 54 (26–87) 0.229
b
Parity 3 (0–8) 2.5 (0–8) 0.631
b
Body mass index (kg/m
2) 21.9 (17.9–32.5) 22.7 (18.1–26.5) 0.753
b
Operating time (minutes) 90 (25–240) 100 (55–125) 0.529
b
Hospital stay (days) 3 (2–10) 7 (4–11) 0.001
b
Diameter of mass (cm) 7 (2–20) 8 (2.5–30) 0.072
b
Hemoglobin change (g/dL) 1.5 (0.3–3.7) 1.5 (0.4–5.3) 0.958
b
Return of bowel activity (h) 29 (18–38) 34.9 (23–72) 0.006
b
Procedures
a 0.295
c
Hysterectomy  BSO 8 11
Hysterectomy  USO 7 0
Hysterectomy  OC 1 0
USO 10 3
OC 5 0
USO  OC 0 1
Oophorectomy 0 1
Complications
Transfusion 1 1 0.621
c
aBSObilateral salpingo-oophorectomy, USOunilateral salpingo-oophorectomy, OCovarian cystectomy.
bMann-Whitney U test.
clinear-by-linear association.
Table 3.
Serum CA 125 Levels According to the Presence or Absence of Ascites in Women With Fibroma, Fibrothecoma, or Cellular Fibroma
Ascites Absent Ascites Present Total P Value
Elevated serum CA 125 2 13 15 0.001
a
Normal serum CA 125 15 2 17
aFisher’s exact test.
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Ovarian fibromas are uncommon but are the most common
benign solid tumor of the ovary. Gynecologists should be
aware of this type of tumor because of the difficulties in
diagnosis. This tumor is often misdiagnosed as a uterine
myoma in ultrasonographic findings and is sometimes mis-
taken for a malignant tumor of the ovary, because of its solid
nature, increased tumor marker levels, and accompanying
ascites. However, ovarian fibromas are benign and can be
treated completely by surgical removal, and laparoscopic
surgery can be an effective and safe alternative approach.
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